Intensity Therapeutics INTS
NASDAQ INTS
$3.21 -0.07 (-2.13%)
As of: Oct 21, 2026 · 9:55 AM EDT

Intensity Therapeutics (INTS) Other non-cash items (2023 - 2026)

Updated

Analysis

Intensity Therapeutics (INTS) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn
10 Intensity Therapeutics 8.69 Mn -30.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 6,000.00
Dec 31, 2024 32,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 6,000.00
Jun 30, 2023 2.26 Mn
Mar 31, 2023 100,000.00
API Access

Intensity Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=INTS&period=max&api_key=YOUR_API_KEY